Skip to main content

Pneumocystis Pneumonia News

FDA Medwatch Alert: Bionpharma Inc. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension Due to Bacterial Contamination

September 17, 2024 – Princeton, NJ, Bionpharma Inc. is voluntarily recalling (1) single Batch (2310083) of Atovaquone Oral Suspension, 750mg per mL to the consumer level. The product was manufactured ...

FDA Medwatch Alert: KVK Tech Inc., Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension, USP 750 mg/5mL Due to Temperature Abuse

KVK Tech, Inc., is voluntarily recalling two lots of Atovaquone Oral Suspension, USP 750 mg/5mLto the consumer level. The recall is based on customer complaints of unusual grittiness in the product,...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Pneumonia

Related drug support groups

clindamycin, Bactrim, trimethoprim, sulfamethoxazole / trimethoprim, Bactrim DS